Humana, Mark Cuban’s Cost Plus Drugs Plan To Offer New Employer Prescription Solutions

On the heels of Capital Blue Cross partnering with the Mark Cuban Cost Plus Drug Co. to make lower-cost biosimilar alternatives to Humira and Stelara available to commercial members, CenterWell Pharmacy (a part of Humana Inc.) announced plans to develop end-to-end employer prescription solutions with Cost Plus Drugs. As part of this collaboration, Cost Plus Drugs’ ...

Read More

Just 10 Minutes Of Daily Floor Exercises May Improve Balance And Agility, Study Finds

Just 10 minutes of daily floor exercises may improve balance, flexibility and agility, according to a new study. Researchers in Japan, including those at the Tokyo University of Agriculture and Technology, found participants improved in standing balance, side-to-side agility and trunk flexibility after completing the specific routine, according to the study, published in April in the journal PLOS ...

Read More

GOP Takes Aim At Hospital CEOs Over Affordability Crisis

House Republicans during a Tuesday hearing blamed hospital and health systems for high health costs, excoriating a group of CEOs for exorbitant benefits packages, large profit margins and mergers. “Our communities are better off with hospitals in them, but large health systems have taken advantage of that reality,” Ways and Means Committee chairman Jason Smith (R-Mo.) said. “Simply put, hospitals are charging an insane amount for care.” ...

Read More

Hospital CEOs Defend Charging Patients More At Facilities

Hospital CEOs came under fire at a House hearing Tuesday, with Republicans accusing them of overcharging patients and exploiting the system. Executives from HCA Healthcare, CommonSpirit Health, New York-Presbyterian and ECU Health testified before the House Ways and Means Committee, defending their pricing practices — including that they should be able to charge higher prices for the same services ...

Read More

Humana Pulls Back The Curtain On Planning For 2027 MA Bids

Humana executives gave investors a peek Wednesday into the company’s thinking around the 2027 Medicare Advantage bid cycle as elevated costs continue to sting the industry. CEO Jim Rechtin said during the insurer’s earnings call that to achieve the goal of returning to a “stable margin” by 2028, it will need to look at adjustments ...

Read More

Health Costs Still A Top Voter Concern, Poll Finds

Health costs continue to top the public’s list of affordability worries, and while Democrats have an edge over Republicans, both parties need to do more to convince independents, according to a new poll from health policy research group KFF. About nine in 10 voters said the issue of health costs will influence their decision to vote and who to vote for in ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square